Jess Fuller and Mike Holroyd have joined the Oncology Imaging Systems (OIS) board of directors. As long-standing members of the OIS team, they each bring a wealth of experience and dedication to their new roles.
Throughout their tenure with the company, they have helped to shape and drive the company forward while embodying its core values of patient focus, integrity, reliability and transparency. As directors, they will play a key role in promoting the company’s continued growth.
Managing director Fuller joined OIS in 2010 with a background in financial administration. She was later promoted to business manager in 2015. Throughout her time at OIS, Fuller has been involved in many areas of the business, including finance, logistics, quality, regulatory, marketing and operations. She has been instrumental in developing company policy and strategy, implementing best practice and optimising operational efficiency.
Holroyd has been appointed sales director from his former role as sales manager. He has a wealth of experience in sales, particularly in the field of radiotherapy and medical physics.
During his 17-year career, Holroyd has been active in various sales roles, many of which were in the field of radiotherapy and medical physics. He joined the OIS sales team in 2014 and was quickly promoted to sales manager. Throughout his tenure, he has played a vital role in helping shape the company into what it is today.
After 23 years as managing director Steve Imber takes on the role of founding director and chair. He said: “Having worked with Jess for nearly 13 years and Mike for nine, I am really pleased and excited about these appointments.”
Picture: Jess Fuller and Mike Holroyd
Published on page 25 of the April 2023 issue of RAD Magazine.